Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP861189.RA15l06-FmLOrmZ6X7SLMAbL_g5LJbDrYWgJMbDjD8vIo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP861189.RA15l06-FmLOrmZ6X7SLMAbL_g5LJbDrYWgJMbDjD8vIo130_assertion type Assertion NP861189.RA15l06-FmLOrmZ6X7SLMAbL_g5LJbDrYWgJMbDjD8vIo130_head.
- NP861189.RA15l06-FmLOrmZ6X7SLMAbL_g5LJbDrYWgJMbDjD8vIo130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861189.RA15l06-FmLOrmZ6X7SLMAbL_g5LJbDrYWgJMbDjD8vIo130_provenance.
- NP861189.RA15l06-FmLOrmZ6X7SLMAbL_g5LJbDrYWgJMbDjD8vIo130_assertion evidence source_evidence_literature NP861189.RA15l06-FmLOrmZ6X7SLMAbL_g5LJbDrYWgJMbDjD8vIo130_provenance.
- NP861189.RA15l06-FmLOrmZ6X7SLMAbL_g5LJbDrYWgJMbDjD8vIo130_assertion SIO_000772 20204404 NP861189.RA15l06-FmLOrmZ6X7SLMAbL_g5LJbDrYWgJMbDjD8vIo130_provenance.
- NP861189.RA15l06-FmLOrmZ6X7SLMAbL_g5LJbDrYWgJMbDjD8vIo130_assertion wasDerivedFrom befree-20140225 NP861189.RA15l06-FmLOrmZ6X7SLMAbL_g5LJbDrYWgJMbDjD8vIo130_provenance.
- NP861189.RA15l06-FmLOrmZ6X7SLMAbL_g5LJbDrYWgJMbDjD8vIo130_assertion wasGeneratedBy ECO_0000203 NP861189.RA15l06-FmLOrmZ6X7SLMAbL_g5LJbDrYWgJMbDjD8vIo130_provenance.